Nirmatrelvir-ritonavir · COVID-19 · FDA fact sheet 02/2026

Paxlovid Eligibility

Step by step: age and weight, severity, days since onset, high-risk conditions, kidney and liver function, and other medicines. The result says whether to prescribe, the label dose for the eGFR, and what to do instead when it cannot be used. For eGFR use the pediatric eGFR tool; for remdesivir and other antivirals see Flu, COVID-19 & RSV.

What this tool decides Nirmatrelvir-ritonavir for teens 12+ and 40 kg+: 5-day window, high risk, eGFR dose, liver and drug interactions.

Tap one answer per step. The plan appears as soon as the answers decide it.